Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus
Recombinant adeno-associated virus (rAAV) vectors are under consideration for a wide variety of gene therapy applications. One of the limitations of the rAAV vector system has been the difficulty in producing the vector in sufficient quantity for adequate preclinical and clinical evaluation. A commo...
Saved in:
Published in | Gene therapy Vol. 6; no. 2; pp. 293 - 299 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Basingstoke
Nature Publishing Group
01.02.1999
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!